What is Definitive Healthcare Corp. (DH)'s fair-value range?

EvidInvest reads Definitive Healthcare Corp. (DH)'s market price back into the assumptions behind it — the implied P/E, growth rate and cash yield — using its latest filed financials, then lets you set your own. See the full DCF, Graham number, EPV and multiple-based methods at https://evidinvest.com/valuation/DH.

How is Definitive Healthcare Corp. (DH)'s fair value calculated?

Definitive Healthcare Corp. (DH)'s fair value is computed with several independent methods — a discounted cash flow (DCF) model, the Graham number, earnings power value (EPV), and valuation multiples such as PE and EV/EBITDA — using data from SEC filings. P/B is optional for non-financial companies and included in the preset range for financial sectors.

Which filing are Definitive Healthcare Corp. (DH)'s valuation inputs based on?

Inputs come from the FY2025 10-K filed 2026-02-26 (accession 0001193125-26-076782). Source: https://www.sec.gov/Archives/edgar/data/1861795/000119312526076782/

Fair value · Definitive Healthcare Corp. (DH) · updated 2026-11-07 · from 10-K FY2025

Definitive Healthcare trades at $1.15. That price implies a 18.4% free-cash-flow yield.

Name: Definitive Healthcare Corp. (DH) valuation inputs and fair-value methods
Creator: EvidInvest
License: https://evidinvest.com/subscription-terms

Cboe · delayed 15 min · as of 20:04 ET

Are those assumptions reasonable? Use DH’s filed growth history and the AI chat to decide, then set your own inputs below — the range you build is yours.

What the price implies

FCF yield: 18.4%

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings. This price: Cboe · delayed 15 min · as of 20:04 ET.

Set your own assumptions ↓See how each method got its number Check another stock

Inputs come from the FY2025 10-K filed 2026-02-26 (accession 0001193125-26-076782); set your own on the sliders below. Research, not investment advice.

The filing behind these numbers

Definitive Healthcare Corp.

Revenue: $241.5M
Diluted EPS: $-1.30
Free cash flow: $37.1M; operating cash flow − capital expenditure
Diluted shares: 106.7M; weighted average

10-K FY2025 · fiscal year ended 2025-12-31 · filed 2026-02-26 · accession 0001193125-26-076782

Trailing-twelve-month EPS also uses the quarterly 10-Qs through Q3 FY2026 (filed 2026-11-05).

Open this filing on sec.gov

Valuation tool: build your own DH range

Fair Value Summary

Daily Price — DH

$1.15 -56.6% (1Y)

Your range1 of 7 methods

At least two methods need a usable value to draw a range with these inputs.

Range with preset inputs

$4.45 – $4.45

Price $1.15

Bear $4.45Base $4.45Bull $4.45

The two ranges are identical because every input sits on a preset.

We don’t tell you what DH is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has DH’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.

Discounted cash flow

N/A

Starting free cash flow is not positive; the model has nothing to grow.

Your stage-1 FCF growth (5.0%) is above the -25.0% the price implies.

Preset inputs — revenue-driven DCF from the latest filing

Two-stage FCF model at the same filed inputs: $4.68 — move any slider below and that model takes over.

• Starting free cash flow is not positive; the model has nothing to grow.

Implied by today’s price

At $1.15 the market implies a stage-1 FCF growth of -25.0%. (two-stage FCF model solved for stage-1 growth at 10.76% WACC)

The price implies stage-1 FCF growth of -25.0%, outside the range this slider covers. Showing preset inputs.

Implied discount rate (holding growth): 33.5% · the WACC that makes the same model print the price

That is the assumption the market is making — not ours, and not a recommendation. Decide whether it is reasonable: the growth matrix shows what DH has actually filed, and the AI chat will reason it through with you.

Your inputs

Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.

Stage-1 growth5.0%

Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.

-20.0%60.0%

Stage-1 years5 yrs

How long stage-1 growth lasts.

1 yrs10 yrs

Stage-2 growth2.5%

Slower growth after stage 1, before the terminal phase.

-20.0%30.0%

Stage-2 years5 yrs

0 yrs10 yrs

Terminal growth2.5%

Growth forever after the two stages. Above ~3% is rarely justified.

0.0%5.0%

Discount rate (WACC)10.76%

The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.

3.00%15.00%

Net debt ($M)Debt minus cash, from the balance sheet. Subtracted from enterprise value.

Starting FCF ($M)Latest free cash flow from the filing (operating cash flow minus capex).

Shares (M)Diluted shares, from the filing.

Year by year (two-stage model, $M)

PV explicit $271M · PV terminal $239M · EV $510M · equity $501M

Year	Stage	FCF	Present value
1	Stage 1	$39M	$35M
2	Stage 1	$41M	$33M
3	Stage 1	$43M	$32M
4	Stage 1	$45M	$30M
5	Stage 1	$47M	$28M
6	Stage 2	$48M	$26M
7	Stage 2	$50M	$24M
8	Stage 2	$51M	$22M
9	Stage 2	$52M	$21M
10	Stage 2	$53M	$19M

Inputs from the filing

Free cash flow: $24.2M; sum of the last four quarters
EBIT: $-224.3M; latest annual
Shares: 106.8M
Total debt: $172.7M
Cash: $163.6M
Net debt: $9.0M; debt − cash

10-K FY2025 · period ended 2025-12-31 · filed 2026-02-26 · accession 0001193125-26-076782 · sec.gov

Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for DH

Loading history...

Download the full DH valuation report (PDF) — free

DCF fair value, Graham number, EPV, key multiples and growth rates in one clean PDF.

Definitive Healthcare trades at $1.15. That price implies a 18.4% free-cash-flow yield.

The filing behind these numbers

Valuation tool: build your own DH range

Daily Price — DH

Your range1 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on DH

Compare with peers

Explore

Valuation tool: build your own DH range

Daily Price — DH

Your range1 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on DH

Compare with peers

Explore